WHO Endorses Cepheid's TB Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The World Health Organization today endorsed Cepheid's Xpert MTB/RIF test for rapid testing of tuberculosis, calling it "a major milestone for global TB diagnosis and care."

WHO is now calling for the fully-automated nucleic acid amplification test to be rolled out under defined conditions as part of national plans for TB and multi-drug resistant TB care and control.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.